Radiopharmaceutical company Lantheus Holdings (NASDAQ: LNTH) will be announcing earnings results this Thursday morning. Here’s what you need to know.
Lantheus missed analysts’ revenue expectations by 2.5% last quarter, reporting revenues of $378 million, down 4.1% year on year. It was a disappointing quarter for the company, with full-year revenue guidance missing analysts’ expectations significantly and a significant miss of analysts’ full-year EPS guidance estimates.
Is Lantheus a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, analysts are expecting Lantheus’s revenue to decline 3.6% year on year to $365 million, a reversal from the 18.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $1.27 per share.
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Lantheus has missed Wall Street’s revenue estimates twice over the last two years.
Looking at Lantheus’s peers in the healthcare equipment and supplies segment, some have already reported their Q3 results, giving us a hint as to what we can expect. Hologic delivered year-on-year revenue growth of 6.2%, beating analysts’ expectations by 1.5%, and GE HealthCare reported revenues up 5.8%, topping estimates by 1.5%. Hologic’s stock price was unchanged after the resultswhile GE HealthCare was down 5.6%.
Read our full analysis of Hologic’s results here and GE HealthCare’s results here.
Investors in the healthcare equipment and supplies segment have had steady hands going into earnings, with share prices flat over the last month. Lantheus is up 8.7% during the same time and is heading into earnings with an average analyst price target of $83.07 (compared to the current share price of $57.30).
P.S. STOP buying the AI stocks everyone’s talking about. The real money? It’s in the profitable pick nobody’s watching yet. We’ve identified an AI profit machine that’s flying under Wall Street’s radar—for now. We can’t keep this research public forever—grab your FREE copy before we pull it offline. GO HERE NOW.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
